Alcon clinical trials
Formerly part of Novartis, Apr 9, 2019 · source ↗
The registry lists 13 studies whose lead sponsor is Alcon. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 14, 2019.
- 13studies on the registry
- 0open to participants now
Before and after it left Novartis
- First submitted before Alcon left Novartis
- 13
- First submitted after Alcon left Novartis
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Alcon’s studies test, most studies first; none is open now — 2 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
All 13 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 14
- 15
- 516
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Alcon, a Novartis Company13 studies
Something wrong with this grouping? Tell us on the Novartis page.
Studies
Recruiting first, then most recently updated. Showing 13 of 13. All Novartis studies →
- Comparison of Topography Guided LASIK With WaveLight® EX500 to SMILE With Zeiss VisuMaxTerminatedNCT02987660Not applicable
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis
- Cataract Refractive Suite StudyTerminatedNCT02974140Not applicable
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis
- Clinical Assessment of a HYDRAGLYDE® RegimenCompletedNCT03026257Not applicable
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis
- OPTI-FREE® PureMoist® for Presbyopic Contact Lens WearersCompletedNCT02965820Not applicable
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis
- CLEAR CARE® PLUS for Presbyopic Contact Lens WearersCompletedNCT02965833Not applicable
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis
- LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye DiseaseCompletedNCT02365519Phase 2
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis
- ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®CompletedNCT02750813Not applicable
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis
- Femtosecond Laser Assisted Cataract Surgery in Intumescent CataractsCompletedNCT02403206Not applicable
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis
- Clinical Assessment of DAILIES TOTAL1® (DT1) MultifocalCompletedNCT02871375Not applicable
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis
- Initial Performance of a Daily Disposable Contact Lens Featuring Molded MarksCompletedNCT02939170Not applicable
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis
- LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular DegenerationCompletedNCT02355028Phase 2
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis
- Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) ImplantationCompletedNCT02450799Not applicable
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis
- Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic SolutionCompletedNCT02325518Phase 4
Sponsor listed in the registry: Alcon, a Novartis Company · First submitted before Alcon left Novartis